成年人黄色毛片,四虎影在线永久免费四虎地址8848aa ,337p西西人体大胆瓣开下部,99久久99久久精品免观看,厨房里摸着乳丰满大屁股,视频一区二区欧美性爱

首頁 > 產(chǎn)品目錄 > 信號通路 > Protein Tyrosine Kinase/RTK > FLT3 > 奎扎替尼

奎扎替尼

ChemLeader 98+%

Quizartinib (AC220)

產(chǎn)品編號:CL2519 CAS No.:950769-58-1 MDLNo: 分子式:C29H32N6O4S 分子量:560.67
規(guī)格 庫存 目錄價 會員專享價 數(shù)量
5 mg 3-5days ¥450.00 登錄后可見
- +
10 mg 3-5days ¥650.00 登錄后可見
- +
25 mg 3-5days ¥950.00 登錄后可見
- +

化學品安全說明書(MSDS)

下載MSDS
  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻
基本信息
英文名稱 Quizartinib (AC220)
中文名稱奎扎替尼
CAS號950769-58-1
分子式C29H32N6O4S
分子量560.67
外觀White to off-white powder
儲存條件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產(chǎn)品詳情

Quizartinib (formerly also know as AC-220; AC-010220, Vanflyta) is a novel, potent, 2nd-generation, and orally bioavailable FLT3 tyrosine kinase inhibitor for Flt3 (ITD/WT) with potential anticancer activity.With IC50s of 1.1 nM and 4.2 nM, respectively, it inhibits FLT3 in MV4-11 and RS4EL11 cells. With respect to KIT, PDGFRα, PDGFRβ, RET, and CSF-1R, it demonstrates a ten-fold greater selectivity. Currently, Daiichi Sankyo is developing quizartinib to treat acute myeloid leukemia. Quizartinib (Vanflyta) was approved in 2023 by FDA for treating AML.

相關(guān)文獻
抱歉,暫時沒有相關(guān)文獻
相關(guān)產(chǎn)品
抱歉,暫時沒有相關(guān)產(chǎn)品
在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時間: 工作日 9:00-18:00